Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News

  News Archive

Engineering Yeast that Speaks
Thursday, July 02, 2015
Scientists at the University of Washington say they have engineered yeast cells that can "talk" to one another, using the plant hormone auxin.

Fast Track Designation for Pneumonia Drug
Thursday, July 02, 2015
Aridis Pharmaceuticals has announced that the FDA has granted Fast Track Designation to its fully human monoclonal antibody Aerucin for the treatment of hospital-acquired and ventilator-associated pneumonia

NuGEN Scientists Screen 400+ Genes for Fusion Events in Single Assay
Thursday, July 02, 2015
Breakthrough proves efficacy of new sample preparation method that could accelerate cancer research and development of treatments and diagnostic tests.

Celgene Launches $1B Immunotherapy Collaboration with Juno
Wednesday, July 01, 2015
Celgene and Juno Therapeutics have launched a 10-year global collaboration to develop and commercialize cancer and autoimmune diseases immunotherapies.

Protein Responsible for Blood Vessel Growth in Tumours Discovered
Wednesday, July 01, 2015
Scientists have discovered a new protein which triggers the growth of blood vessels in breast cancer tumours which have spread to the brain, a common location which breast cancer can spread to.

EU Recommends Approval for Alexion's Rare Disease Drugs
Tuesday, June 30, 2015
Alexion Pharmaceuticals announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted positive opinions recommending marketing authorization of Strensiq (asfotase alfa) and Kanuma (sebelipase alfa).

Epigenetic Switches that turn Stem Cells into Blood Vessel Cells Uncovered
Monday, June 29, 2015
Researchers at the University of Illinois have identified a molecular mechanism that directs embryonic stem cells to mature into endothelial cells.

Human Trials of Manufactured Blood Within Two Years
Monday, June 29, 2015
The first human trials of lab-produced blood to help create better-matched blood for patients with complex blood conditions has been announced by NHS Blood and Transplant.

Novartis Acquires Spinifex Pharmaceuticals, Inc.
Monday, June 29, 2015
Acquisition adds novel angiotensin II Type 2 receptor antagonist for the treatment of neuropathic pain to Novartis' industry-leading development pipeline.

<< 1 2 3 4 5 6 7 >>
Showing Results 31 - 40 of 2364
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!